Ruslan Grishanin Email

VP, Nonclinical Development . Adverum Biotechnologies

Current Roles

Employees:
177
Revenue:
$34.3M
About
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration. For more information, please visit www.adverum.com.
Adverum Biotechnologies Address
100 Cardinal Way
Redwood City, CA
United States
Adverum Biotechnologies Email

Past Companies

Adverum BiotechnologiesVice President, Nonclinical Development
Adverum Biotechnologies, Inc.Executive Director
Adverum Biotechnologies, Inc.Director, Preclinical Development

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.